LS-1100 uses the advanced method of Time-resolved Fluorescence Immunoassay (TRFIA), for the in-vitro quantitative detection of bio-markers for diabetes, infectious diseases, cardiovascular diseases, sex hormones, gastric diseases, thyroid function, tumors, COVID-19 and other diseases. Application: laboratory, emergency , ICU, clinical laboratory, clinic, ambulance, field rescue and other clinical departments, etc.
Specifications:
Method | Time-resolved Fluorescence Immunoassay (TRFIA) |
Specimen | Serum/Plasma/Whole Blood/Nasal swab |
Weight | 1.3kg |
Dimensions | 225mm×152mm×105mm (L×W×H) |
Screen | 7 inch touch screen |
Data Storage | 10000 |
Printer | Built-in thermal printer |
Battery | Built-in lithium battery |
Communication | RS232(LIS/HIS), USB |
Test Items:
Diabetes | HbA1c |
Inflammation | CRP, hs-CRP, PCT, SAA, SAA/CRP, PCT/CRP, IL-6 |
Cardiac | CK-MB, cTnI, Myo, cTnI/CK-MB/Myo, NT-proBNP, BNP, D-Dimer, H-FABP, FDP, ST2 |
Sex hormone | β-HCG, LH, FSH, PRL, AMH, Progesterone, E2, T |
Thyroid | TT3, TT4, FT3, FT4, TSH |
Bone Metabolism | 25-OH-VD |
Gastric Function | PGI/PGII, G-17 |
Anemia | Ferritin, B12 |
Tumour | PSA, fPSA |
Brain Injury | S100-β |
Angiocarpy | HCY |
Renal Function | mAlB, NGAL |
Immune System | IgG4, CCP, IgE, ASO, RF |
Nervous System | Aβ1-42, P-tau-181, AD7c-NTP |
COVID-19 | COVID-19 Antigen, SARS-CoV-2 Neutralizing Antibodies, (COVID-19) IgM/IgG |
Monkeypox Virus | Monkeypox Virus Antibody |